Abstract
The 22q11.2 microdeletion syndrome (22q11.2 DGS) is characterized by an extreme intrafamilial and interfamilial variability. The main clinical features are congenital heart defects, palatal abnormalities, learning disability, facial dysmorphisms and immune deficiency. In 85–90% of cases, the 22q11.2 DGS is caused by a heterozygous ~3-Mb deletion, including the TBX1 gene, considered one of the major genes responsible for heart defects. Individuals with atypical deletions with at least one breakpoint outside low copy repeats have been reported. Our patient is a child presenting tetralogy of Fallot (TOF) with an atypical 22q11.2 deletion proximal to the critical DiGeorge region. The rearrangement was inherited from the healthy mother and spanned ~642–970 kb, encompassing DGCR6 and PRODH, two novel possible candidate genes for conotruncal heart defects.
This is a preview of subscription content, log in via an institution to check access.
References
Amati F., Conti E., Novelli A., Bengala M., Diglio M. C., Marino B. et al. 1999 Atypical deletions suggest five 22q11.2 critical regions related to the DiGeorge/velo-cardio-facial syndrome. Eur. J. Hum. Genet. 8, 903–909.
Beaujard M-P., Chantot S., Dubois M., Keren B., Carpentier W., Mabboux P. et al. 2009 Atypical deletion of 22q11.2: detection using the FISH TBX1 probe and molecular characterization with high-density SNP arrays. Eur. J. Med. Genet. 52, 321–327.
Burnside R. D. 2015 22q11.21 Deletion Syndromes: A review of proximal, central, and distal deletions and their associated features. Cytogenet. Genome Res. 146, 89–99.
Das Chakraborty R., Chakraborty D., Bernal A. J., Schoch K., Howard T. D., Ip E. H., et al. 2012 Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome. Transl. Psychiatry. 2, e105.
de la Morena M. T., Eitson J. L., Dozmorov I. M., Belkaya S., Hoover A. R., Anguiano E. et al. 2013 Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome. Clin. Immunol. 147, 11–22.
Dykes I. M., van Bueren K. L., Ashmore R. J., Floss T., Wurst W., Szumska D. et al. 2014 HIC2 is a novel dosage-dependent regulator of cardiac development located within the distal 22q11 deletion syndrome region. Circ. Res. 115, 23–31.
Edelmann L., Pandita R. K. and Morrow B. E. 1999 Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am. J. Hum. Genet. 64, 1076–1086.
Gao W., Higaki T., Eguchi-Ishimae M., Iwabuki H., Wu Z., Yamamoto E. et al. 2015 DGCR6 at the proximal part of the DiGeorge critical region is involved in conotruncal heart defects. Hum. Genome. Var. 2, 15004.
Hierck B. P., Molin D. G. M., Boot M. J., Poelmann R. E. and Gittenberger-de Groot A. C. 2004 A chicken model for DGCR6 as a modifier gene in the DiGeorge critical region. Pediatr. Res. 56, 440–448.
Keyte A. L., Alonzo-Johnsen M. and Hutson M. R. 2014 Evolutionary and developmental origins of the cardiac neural crest: building a divided outflow tract. Birth Defects Res. C. Embryo. Today 102, 309–323.
Lonfat N., Montavon T., Jebb D., Tschopp P., Nguyen Huynh T. H., Zakany J. et al. 2013 Transgene- and locus-dependent imprinting reveals allele-specific chromosome conformations. Proc. Natl. Acad. Sci. USA 110, 11946–11951.
Lu J. H., Chung M. Y., Betau H., Chien H. P. and Lu J. K. 2001 Molecular characterization of tetralogy of fallot within Digeorge critical region of the chromosome 22. Pediatr. Cardiol. 22, 279–284.
McDonald-McGinn D. M., Hain H. S., Emanuel B. S. and Zackai E. H. 1999 22q11.2 Deletion syndrome. In GeneReviews (ed. M. P. Adam, H. H. Ardinger, R. A. Pagon, et al.). University of Washington, (Available from: https://www.ncbi.nlm.nih.gov/books/NBK1523/).
McDonald-McGinn D. M., Zackai E. H. and Kohut T. 2010 Deletion 22q11.2 (velo-cardio-facial syndrome/DiGeorge syndrome). Cassidy SB Allanson JE Eds. Manag. Genet. Syndr. 3o ed. Wiley-Blackwell.
Merico D., Costain G., Butcher N. J., Warnica W., Ogura L., Alfred S. E. et al. 2014 MicroRNA dysregulation, gene networks, and risk for schizophrenia in 22q11.2 deletion syndrome. Front. Neurol. 5, 238.
Moon A. M., Guris D. L., Seo J., Li L., Hammond J., Talbot A. et al. 2006 Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes. Dev. Cell. 10, 71–80.
Newbern J., Zhong J., Wickramasinghe R. S., Li X., Wu Y., Samuels I. et al. 2008 Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc. Natl. Acad. Sci. USA 105, 17115–17120.
Yagi H., Furutani Y., Hamada H., Sasaki T., Asakawa S., Minoshima S. et al. 2003 Role of TBX1 in human del22q11.2 syndrome. Lancet 362, 1366–1373.
Zeitz M. J., Lerner P. P., Ay F., Van Nostrand E., Heidmann J. D., Noble W. S. et al. 2013 Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome. Nucleus 4, 487–493.
Zhao Y., Diacou A., Johnston H. R., Musfee F. I., McDonald-McGinn D. M., McGinn D. et al. 2020 Complete sequence of the 22q11.2 allele in 1,053 Subjects with 22q11.2 deletion syndrome reveals nodifiers of conotruncal heart defects. Am. J. Hum. Genet. 106, 26–40.
Acknowledgements
We are indebted to the family members who participated in this study. We thank Cristina Digilio for critical reading and suggestions, and Forma Onlus Foundation for support in the care of children and families with rare paediatric diseases.
Author information
Authors and Affiliations
Corresponding author
Additional information
Corresponding editor: H. A. Ranganath
Rights and permissions
About this article
Cite this article
Carli, D., Moroni, A., Eleonora, D.G. et al. Atypical microdeletion 22q11.2 in a patient with tetralogy of Fallot. J Genet 100, 5 (2021). https://doi.org/10.1007/s12041-020-01257-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12041-020-01257-z